$188 Million is the total value of DSC Advisors, L.P.'s 73 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EWJ | Exit | ISHAREScall | $0 | – | -200,000 | -100.0% | -0.00% | – |
| GILD | Exit | GILEAD SCIENCES INCcall | $0 | – | -60,000 | -100.0% | -0.01% | – |
| URI | Exit | UNITED RENTALS INCput | $0 | – | -100,000 | -100.0% | -0.01% | – |
| MAN | Exit | MANPOWERGROUP INCcall | $0 | – | -80,000 | -100.0% | -0.01% | – |
| Exit | SEADRILL LIMITEDcall | $0 | – | -100,000 | -100.0% | -0.02% | – | |
| XNY | Exit | CHINA XINIYA FASHION LTDsponsrd adr new | $0 | – | -50,000 | -100.0% | -0.03% | – |
| AMZN | Exit | AMAZON COM INC | $0 | – | -1,680 | -100.0% | -0.15% | – |
| JASNW | Exit | JASON INDS INC*w exp 06/30/201 | $0 | – | -667,580 | -100.0% | -0.23% | – |
| DIA | Exit | SPDR DOW JONES INDL AVRG ETFput | $0 | – | -600,000 | -100.0% | -0.23% | – |
| ORPN | Exit | BIO BLAST PHARMA LTD | $0 | – | -171,360 | -100.0% | -0.32% | – |
| RSYS | Exit | RADISYS CORP | $0 | – | -550,000 | -100.0% | -0.37% | – |
| ENTR | Exit | ENTROPIC COMMUNICATIONS INC | $0 | – | -650,000 | -100.0% | -0.48% | – |
| IAU | Exit | ISHARES GOLD TRUSTishares | $0 | – | -148,098 | -100.0% | -0.49% | – |
| ZNGA | Exit | ZYNGA INCcl a | $0 | – | -800,000 | -100.0% | -0.62% | – |
| FXE | Exit | CURRENCYSHARES EURO TR | $0 | – | -21,564 | -100.0% | -0.74% | – |
| TRN | Exit | TRINITY INDS INC | $0 | – | -294,200 | -100.0% | -2.39% | – |
| VNQ | Exit | VANGUARD INDEX FDSreit etf | $0 | – | -106,120 | -100.0% | -2.49% | – |
| BKD | Exit | BROOKDALE SR LIVING INC | $0 | – | -250,000 | -100.0% | -2.66% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CVS HEALTH CORP | 39 | Q3 2023 | 21.2% |
| MICROSOFT CORP | 38 | Q3 2023 | 2.9% |
| APPLE INC | 37 | Q3 2023 | 2.7% |
| META PLATFORMS INC | 37 | Q3 2023 | 1.6% |
| UNITEDHEALTH GROUP INC | 37 | Q3 2022 | 1.5% |
| ORACLE CORP | 35 | Q3 2023 | 0.6% |
| INTERNATIONAL BUSINESS MACHS | 33 | Q3 2022 | 0.6% |
| ALPHABET INC | 32 | Q3 2023 | 16.0% |
| ALPHABET INC | 32 | Q3 2023 | 2.6% |
| SALESFORCE INC | 30 | Q3 2023 | 0.9% |
View DSC Advisors, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| BioScrip, Inc. | March 12, 2015 | 1,842,241 | 2.7% |
| TARRAGON CORPSold out | February 25, 2009 | 0 | 0.0% |
| OGLEBAY NORTON CO /NEW/Sold out | September 29, 2006 | 0 | 0.0% |
| JORGENSEN EARLE M CO /DE/ | August 08, 2005 | 2,444,200 | 5.0% |
| AFFIRMATIVE INSURANCE HOLDINGS INC | June 15, 2005 | 1,159,699 | 7.8% |
| VESTA INSURANCE GROUP INCSold out | December 30, 2004 | 0 | 0.0% |
| HANGER ORTHOPEDIC GROUP INC | November 08, 2004 | 1,103,900 | 5.1% |
View DSC Advisors, L.P.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View DSC Advisors, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.